MEDP240816P270000
- 0.20
- 0.000.00%
Medpace Newsroom
Truist Financial Maintains Medpace(MEDP.US) With Hold Rating, Maintains Target Price $415
Express News | Medpace Holdings Inc : Truist Securities Initiates With Hold Rating; Price Target $415
Truist Financial Initiates Medpace(MEDP.US) With Hold Rating, Announces Target Price $415
Express News | Truist Securities Initiates Coverage On Medpace Hldgs With Hold Rating, Announces Price Target of $415
Medpace Hldgs Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Medpace Holdings (MEDP) and Roche Holding AG (OtherRHHVF)
Looking Into Medpace Hldgs's Recent Short Interest
Ford, Stellantis And Dell Are Among Top 12 Large Cap Losers Last Week (July 21-July 27): Are The Others In Your Portfolio?
Strong performance cannot withstand the decline of key indicators, Medpace is in trouble(MEDP.US).
As the stock price and performance continue to reach new highs, the market has higher expectations for Medpace's performance. However, key indicators in the second quarter of this year suggest signs of slowing performance for the company.
Here's How Much $100 Invested In Medpace Hldgs 5 Years Ago Would Be Worth Today
Medpace Holdings, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Medpace Holdings, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Express News | Medpace Holdings Shares Are Trading Higher After Falling on Tuesday Following Q2 Earnings
Medpace Holdings Price Target Cut to $336.00/Share From $395.00 by Deutsche Bank
Expert Ratings For Medpace Hldgs
A Quick Look at Today's Ratings for Medpace(MEDP.US), With a Forecast Between $430 to $480
Deutsche Bank Adjusts Medpace Holdings Price Target to $336 From $395, Maintains Hold Rating
Medpace Holdings Is Maintained at Buy by Guggenheim
Medpace Holdings Second Quarter 2024 Earnings: EPS Beats Expectations
Express News | Guggenheim Maintains Buy on Medpace Hldgs, Lowers Price Target to $432